About Resilience-h2020
RESILIENCE Proyect
A European Commission-funded project aimed at reducing the incidence of heart failure in cancer survivors
Cancer survivors are at high risk for cardiovascular complications. Anthracyclines are an extremely effective treatment against many cancer types, but they can induce cardiac toxicity resulting in chronic heart failure.
RESILIENCE Project tests a novel preventive intervention (remote ischemic conditioning) in patients at risk for anthracycline-induced cardiotoxicity. In addition, new diagnostic modalities will be used to identify anthracyclines-induced cardiotoxicity in its very early stages.
RESILIENCE counts on a multidisciplinary consortium with the active participation of patients.
Similar Apps
CNIC App
Welcome to the new CNIC app!We are pleased to introduce our new...
HF4HF
HF4HF es una aplicación diseñada para un estudio médico que evalúa cómo...
REACT Study
REACT (Early Cure of Atherosclerosis) is an innovative app designed to support...
ATTRACKING
Simplify medical management by discharging patients and uploading documents directly to the...
CNIC
App for CNIC employees.- Access to news.- Double factor authentication.- Reservation of...
